3 European Stocks That Could Be Undervalued By Up To 49.4%

Amidst a backdrop of tentative optimism surrounding potential EU-U.S. trade deals, the European markets have shown resilience, with the pan-European STOXX Europe 600 Index rising modestly. As investors navigate this period of economic uncertainty and slightly hawkish signals from the European Central Bank, identifying undervalued stocks becomes crucial for those looking to capitalize on potential market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Click here to see the full list of 191 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener.

Next Geosolutions Europe (BIT:NXT)

Overview: Next Geosolutions Europe SpA offers marine geoscience and offshore construction support services across Europe, Asia, and North America, with a market cap of €499.20 million.

Operations: The company's revenue is primarily derived from its engineering services segment, which generated €304.99 million.

Estimated Discount To Fair Value: 48.7%

Next Geosolutions Europe is trading at €10.4, significantly below its estimated fair value of €20.28, highlighting its undervaluation based on cash flows. The stock is priced attractively compared to peers and the industry, with a forecasted earnings growth of 20.7% annually over the next three years, outpacing the Italian market's 8.2%. Despite a decrease in profit margins from last year, NXT maintains high-quality non-cash earnings and a robust future return on equity projection of 25.1%.

• Our earnings growth report unveils the potential for significant increases in Next Geosolutions Europe's future results.
• Take a closer look at Next Geosolutions Europe's balance sheet health here in our report.

Pexip Holding (OB:PEXIP)

Overview: Pexip Holding ASA is a video technology company that offers an end-to-end video conferencing platform and digital infrastructure across various regions, with a market capitalization of NOK6.48 billion.

Operations: The company's revenue is primarily generated from the sale of collaboration services, amounting to NOK1.17 billion.

Estimated Discount To Fair Value: 12.2%

Pexip Holding, trading at NOK64.5, is undervalued compared to its estimated fair value of NOK73.46, reflecting potential based on cash flows. The company's earnings are forecast to grow significantly at 25.5% annually, surpassing the Norwegian market's growth rate of 10.8%. Recent earnings reports show a rise in net income and sales year-over-year for Q1 2025. Additionally, Pexip announced a share repurchase program worth NOK100 million to fulfill future share-based compensation obligations.

• Our growth report here indicates Pexip Holding may be poised for an improving outlook.
• Get an in-depth perspective on Pexip Holding's balance sheet by reading our health report here.

Diagnostyka (WSE:DIA)

Overview: Diagnostyka S.A. operates as a medical laboratory with a market cap of PLN6.19 billion.

Operations: The company's revenue primarily comes from its Medical Labs & Research segment, generating PLN2.06 billion.

Estimated Discount To Fair Value: 49.4%

Diagnostyka S.A., trading at PLN183.25, is significantly undervalued compared to its estimated fair value of PLN362.3, presenting potential based on cash flows. Despite high debt levels, the company's earnings are forecast to grow annually by 17%, outpacing the Polish market's 13.5% growth rate, with revenue growth expected at 10.8% per year. Recent inclusion in the S&P Global BMI Index highlights increased investor attention and recognition in broader markets.

• The growth report we've compiled suggests that Diagnostyka's future prospects could be on the up.
• Click here and access our complete balance sheet health report to understand the dynamics of Diagnostyka.

Key Takeaways

• Explore the 191 names from our Undervalued European Stocks Based On Cash Flows screener here.
• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com